D.E. Shaw & Co
IDYA icon

D.E. Shaw & Co’s IDEAYA Biosciences IDYA Stock Holding History

D.E. Shaw & Co’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-98,153
Closed -$2.06M – 4728
2025
Q2 		$2.06M Sell
98,153
-210,403
-68% -$4.04M ﹤0.01% 2723
2025
Q1 		$5.05M Buy
308,556
+127,880
+71% +$2.72M ﹤0.01% 1881
2024
Q4 		$4.64M Sell
180,676
-387,055
-68% -$11M ﹤0.01% 2042
2024
Q3 		$18M Sell
567,731
-316,807
-36% -$12M 0.02% 1045
2024
Q2 		$31.1M Buy
884,538
+226,514
+34% +$8.97M 0.03% 655
2024
Q1 		$28.9M Buy
658,024
+128,518
+24% +$5.53M 0.02% 712
2023
Q4 		$18.8M Buy
529,506
+93,148
+21% +$2.78M 0.02% 963
2023
Q3 		$11.8M Buy
436,358
+223,143
+105% +$5.66M 0.01% 1174
2023
Q2 		$5.01M Buy
213,215
+116,156
+120% +$2.39M 0.01% 1853
2023
Q1 		$1.33M Buy
97,059
+76,118
+363% +$1.27M ﹤0.01% 2965
2022
Q4 		$380K Buy
+20,941
New +$352K ﹤0.01% 3987
2022
Q2 		– Sell
-24,590
Closed -$275K – 5520
2022
Q1 		$275K Sell
24,590
-22,927
-48% -$338K ﹤0.01% 4702
2021
Q4 		$1.12M Buy
47,517
+27,710
+140% +$644K ﹤0.01% 3834
2021
Q3 		$505K Buy
+19,807
New +$462K ﹤0.01% 4079
2021
Q2 		– Sell
-19,293
Closed -$453K – 4861
2021
Q1 		$453K Sell
19,293
-9,904
-34% -$191K ﹤0.01% 3549
2020
Q4 		$409K Buy
+29,197
New +$396K ﹤0.01% 3481

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

D.E. Shaw & Co's IDYA Position: Q3 2025 in Review

D.E. Shaw & Co sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 98,153 shares — an estimated $2.06M sold.

D.E. Shaw & Co first reported a position in IDYA in Q4 2020 and held it in 16 quarters. The position peaked at $31.1M in Q2 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • D.E. Shaw & Co reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 98,153 IDEAYA Biosciences shares in Q3 2025, an estimated $2.06M.
  • D.E. Shaw & Co first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 16 quarters.
  • D.E. Shaw & Co's IDEAYA Biosciences position peaked at $31.1M in Q2 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.